Ifoxetine
| Ifoxetine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Ifoxetine is a selective serotonin reuptake inhibitor (SSRI) that was investigated for its potential use as an antidepressant. SSRIs are a class of drugs that are typically used to treat major depressive disorder and anxiety disorders by increasing the levels of serotonin in the brain.
Mechanism of Action[edit]
Ifoxetine works by inhibiting the reuptake of serotonin (5-HT) into the presynaptic cell, increasing the levels of serotonin available to bind to the postsynaptic receptor. This mechanism is similar to that of other SSRIs such as fluoxetine, sertraline, and citalopram.
Clinical Trials[edit]
Although ifoxetine showed promise in early clinical trials, it did not progress to become a widely used medication. The reasons for this could include a lack of significant efficacy compared to existing treatments, potential side effects, or other factors that are common in the drug development process.
Side Effects[edit]
As with other SSRIs, potential side effects of ifoxetine may include nausea, headache, sexual dysfunction, and insomnia. The side effect profile of ifoxetine would likely be similar to that of other drugs in its class.
Comparison with Other SSRIs[edit]
Ifoxetine is part of the same class of drugs as fluoxetine (Prozac), sertraline (Zoloft), and paroxetine (Paxil). These medications are commonly prescribed for depression, anxiety disorders, and other conditions. The choice of SSRI can depend on the specific symptoms, side effect profiles, and individual patient response.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
